Arizona - February 2014 Archives

SCOTTSDALE, Ariz. — Feb. 26, 2014 — The future holds promise for multiple sclerosis research based on advancements of the past two decades according to a review from Mayo Clinic neurologists published in Mayo Clinic Proceedings. The paper states that many people with newly diagnosed or early stage MS are overwhelmed by the combination of uncertain prognosis and the often-unsettling prospect of starting preventive measures that are used indefinitely. However, the authors say that patients and physicians can benefit from an awareness of recent and emerging developments. “MS is the second most common disabling disease of young adults - it is a lifelong disease with an unpredictable clinical course for the most part,” said Dean Wingerchuk, M.D., Mayo Clinic neurologist and co-author of the review. “That means that people are challenged with making decisions about treatment. It’s important for both the patient and physicians to be aware of current and emerging therapies  to make appropriate decisions going forward.” http://www.youtube.com/watch?v=yDgap-v9yXE&feature=youtu.be Journalists: Sound bites with Dr. Wingerchuk are available in the downloads. Dr. Wingerchuk said that MS research has been prolific and that scientific advances in understanding the relapsing form of the disease have led to the recent development of several new treatments.